Virbac S.A.
VIRP
Rank in Stocks
#4512
Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent... Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent developer and distributor of a wide array of animal health products and services. The company's global operations extend across France, Europe, Latin America, North America, Asia Pacific, the Middle East, and Africa, catering to both domestic companion animals and commercial livestock. Its extensive portfolio encompasses vaccines, dental hygiene products, reproductive health solutions, dermatological treatments, parasiticides, diagnostic instruments, antibiotics, and aquaculture offerings. Furthermore, Virbac supplies specialized veterinary pharmaceuticals for anesthesia, geriatric care, behavioral management, and injectable micronutrients, alongside pet food and electronic identification systems. These diverse solutions are designed to support veterinarians, agricultural producers, and individual pet owners worldwide.
Share Price
$408.63
Market Cap
$3.42B
Change (1 day)
2.23%
Change (1 year)
2.77%
Country
FR
Trade Virbac S.A. (VIRP)
Category
Healthcare
Earnings for Virbac S.A. (VIRP)
Earnings in Jun 2026 TTM: $265.58M
According to Virbac S.A. latest financial reports the company's current earnings are $265.58M. In 2023 the company made an earning of $192.52M, an increase over its 2022 earnings that were of $189.27M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Virbac S.A. from 2002 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $265.58M | 22.55% |
| 2024 | $216.71M | 12.56% |
| 2023 | $192.52M | 1.72% |
| 2022 | $189.27M | 10.86% |
| 2021 | $170.73M | -19.12% |
| 2020 | $211.09M | 141.63% |
| 2019 | $87.36M | 83.84% |
| 2018 | $47.52M | -3.41% |
| 2017 | $49.20M | -11.53% |
| 2016 | $55.61M | 250.68% |
| 2015 | $15.86M | -86.85% |
| 2014 | $120.60M | -7.42% |
| 2013 | $130.28M | 3.46% |
| 2012 | $125.92M | 16.49% |
| 2011 | $108.09M | -6.13% |
| 2010 | $115.16M | 42.50% |
| 2009 | $80.81M | 15.08% |
| 2008 | $70.22M | -0.38% |
| 2007 | $70.49M | 41.66% |
| 2006 | $49.76M | 37.75% |
| 2005 | $36.13M | 5.39% |
| 2004 | $34.28M | 0.00% |
| 2003 | 0.00 | 0.00% |
| 2002 | 0.00 | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $33.60B | 12,550.12% |
US
|
|
| $17.74B | 6,578.71% |
US
|
|
| $8.70B | 3,175.53% |
US
|
|
| $5.95B | 2,139.67% |
US
|
|
| $21.39B | 7,953.57% |
CH
|
